Truvestments Capital LLC Purchases Shares of 7,507 Proto Labs, Inc. $PRLB

Key Points

• Truvestments Capital LLC acquired 7,507 shares of Proto Labs, Inc. for approximately $263,000 during the first quarter, as reported in their recent SEC filing.
• Proto Labs reported a quarterly earnings per share of $0.41, exceeding the consensus estimate of $0.33 and marking a year-over-year revenue increase of 7.6% to $135.06 million.
• Brokerages have upgraded Proto Labs' stock ratings, with Wall Street Zen raising it to a "strong-buy", indicating increased confidence in the company's market performance.

Truvestments Capital LLC bought a new stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,507 shares of the industrial products company's stock, valued at approximately $263,000.

Several other large investors have also modified their holdings of PRLB. GAMMA Investing LLC grew its position in Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after buying an additional 661 shares during the last quarter. Quarry LP raised its position in Proto Labs by 175.7% during the 4th quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock worth $62,000 after buying an additional 1,010 shares during the last quarter. CWM LLC lifted its stake in shares of Proto Labs by 50.4% in the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after acquiring an additional 617 shares during the period. PNC Financial Services Group Inc. boosted its holdings in shares of Proto Labs by 14.1% in the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after acquiring an additional 267 shares in the last quarter. Finally, Lazard Asset Management LLC increased its stake in shares of Proto Labs by 182.3% during the fourth quarter. Lazard Asset Management LLC now owns 5,875 shares of the industrial products company's stock worth $228,000 after acquiring an additional 3,794 shares during the period. Hedge funds and other institutional investors own 84.54% of the company's stock.

Insiders Place Their Bets

In other news, CEO Suresh Krishna purchased 1,725 shares of the company's stock in a transaction dated Monday, August 4th. The stock was acquired at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the transaction, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. This represents a 10.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.20% of the company's stock.

Proto Labs Price Performance

Proto Labs stock traded down $1.08 during mid-day trading on Monday, reaching $49.69. The company had a trading volume of 207,182 shares, compared to its average volume of 185,243. Proto Labs, Inc. has a 1 year low of $26.34 and a 1 year high of $51.09. The company has a market capitalization of $1.19 billion, a P/E ratio of 82.81 and a beta of 1.27. The stock's 50-day simple moving average is $43.29 and its 200-day simple moving average is $39.47.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.33 by $0.08. The business had revenue of $135.06 million for the quarter, compared to analyst estimates of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The company's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.38 EPS. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, equities analysts forecast that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research report on Friday, August 1st. Wall Street Zen raised Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Finally, Cantor Fitzgerald upped their price objective on Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $52.50.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.